CluenexExelon EXC
Exelon scores weak on business quality (4.4 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What Exelon does
Exelon operates regulated electric and gas distribution utilities serving millions of customers across major urban centers, collecting steady delivery rates approved by state regulators.
- What it does best
Exelon dominates densely populated urban utility markets where scale creates unmatched grid maintenance efficiency. Its gross margin sits at 63.5%, compared to CEG's 43.9%, highlighting superior transmission density.
- The main risk
Regulatory dependence threatens payouts, as Exelon's 4.07% dividend yield relies entirely on state utility commission approvals while net debt climbs to $49.5 billion.
Quality, check by check
Scored against its own industry, from company filings.
Operating margin stands at 20.8% with an ROE of 9.6%, lagging sector medians. Heavy capital expenditure keeps free cash flow negative, meaning scale requires more debt.
Monopoly distribution franchises lock in regional consumers and municipalities. The gross margin ranks in the lower sector percentiles at 33, limiting pricing power.
Revenue grows at a 5.3% rate to $25.3 billion, sitting in the bottom quartile at the 30th sector percentile for growth as capital investments constrain cash generation.
Total debt reaches $50.1 billion with interest coverage at just 2.4x. Free cash flow is negative $1.9 billion due to heavy capital spending, leaving the balance sheet soft.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
No open market buys or unplanned sales by executives or directors.
Our sealed record on EXC
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
Exelon scores weak on the Cluenex quality check (4.4 of 10), measured against its own industry. Profitability is weak, moat fair, growth slow and financial health fair.
In the last 90 days of SEC Form 4 filings: No open market buys or unplanned sales by executives or directors.
Oct 30, 2026, before the open.
See EXC today
- Today's verdict on EXC, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “Exelon (EXC)”, https://cluenex.com/stocks/exc/, data as of Oct 10, 2026.